Cargando…
Key points to keep in mind related to COVID-19 vaccines in people with multiple sclerosis
Vaccinations are often the most effective tool against certain diseases known to mankind, and their interaction with multiple sclerosis (MS) has been discussed for decades. With rapidly accumulating numbers of cases and deaths due to COVID-19, there is a global effort to respond to this pandemic in...
Autores principales: | Galleguillos, Lorna, Alonso, Ricardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284074/ https://www.ncbi.nlm.nih.gov/pubmed/34298479 http://dx.doi.org/10.1016/j.msard.2021.103142 |
Ejemplares similares
-
COVID-19 in a multiple sclerosis (MS) patient treated with alemtuzumab: Insight to the immune response after COVID
por: Fiorella, Celsi, et al.
Publicado: (2020) -
Evaluation of short-term safety of COVID-19 vaccines in patients with
multiple sclerosis from Latin America
por: Alonso, Ricardo, et al.
Publicado: (2021) -
Multiple Sclerosis, COVID-19 and Vaccines: Making the Point
por: Toscano, Simona, et al.
Publicado: (2021) -
Experience of South American MS and/or NMOSD experts in practice during the COVID-19 pandemic: Focus on Telemedicine
por: Alonso, Ricardo, et al.
Publicado: (2021) -
The persona lifecycle: keeping people in mind throughout product design
por: Pruitt, John, et al.
Publicado: (2006)